Nordic Completes $846m Takeover Of Advanz
Firm Plans ‘Considerable Investment In Our Organic And Inorganic Pipeline’
Nordic Capital has completed its takeover of Advanz Pharma, three years after the company’s transformation from its former identity of Concordia. The company is planning “considerable investment” following the deal.
You may also be interested in...
The Generics Bulletin Top 50, Part Three: Newcomers Climb Into Bottom Table
In the third section of this year’s Generics Bulletin Top 50, a handful of new entrants make their way into the bottom of the rankings, while some volatility is seen among longstanding ranking companies.
Burden Departs Advanz As Intercept Deal Completes
As Advanz completes its deal to acquire Intercept’s ex-US business, the company has confirmed a management change that has seen chief commercial officer Paul Burden leave the company, with the appointment of two new regional CCOs.
Musical Chairs For Off-Patent Executives In 2021
Last year was a year of significant executive changes in the off-patent industry, with numerous high-profile hires and departures from companies like Sandoz, Teva, Viatris, Hikma, Fresenius, Neuraxpharm and Stada.